Marimed (MRMD) Invested Capital (2011 - 2026)

Marimed (MRMD) has 16 years of Invested Capital data on file, last reported at $50.0 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $50.0 million, down 18.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.0 million (down 18.97% YoY), and the FY2025 annual result was $54.1 million, down 13.5% from the prior year.
• Invested Capital retreated to $50.0 million in Q1 2026 per MRMD's latest filing, from $54.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $83.2 million in Q2 2023 and troughed at $44.1 million in Q1 2022.
• A 5-year average of $63.0 million and a median of $61.7 million in 2025 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2026: Invested Capital surged 198.69% in 2022, then declined 18.97% in 2026.
• A 5-year view of Invested Capital shows it stood at $60.3 million in 2022, then increased by 19.83% to $72.2 million in 2023, then dropped by 13.49% to $62.5 million in 2024, then retreated by 13.5% to $54.1 million in 2025, then retreated by 7.47% to $50.0 million in 2026.
• Business Quant data shows MRMD's Invested Capital at $50.0 million in Q1 2026, $54.1 million in Q4 2025, and $58.7 million in Q3 2025.